| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,888 |
4,002 |
$131K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
949 |
908 |
$84K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,915 |
3,355 |
$76K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
536 |
496 |
$31K |
| 80053 |
Comprehensive metabolic panel |
9,520 |
7,383 |
$23K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,293 |
1,178 |
$22K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,382 |
1,204 |
$19K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
580 |
428 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,453 |
7,109 |
$16K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,085 |
739 |
$14K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,599 |
1,055 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
1,204 |
867 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,735 |
1,504 |
$10K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
308 |
114 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
12,480 |
9,464 |
$8K |
| 87070 |
|
457 |
411 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,329 |
1,649 |
$7K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,015 |
744 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,243 |
1,767 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
65 |
63 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
486 |
460 |
$5K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
471 |
433 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,085 |
1,654 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,674 |
1,560 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34 |
31 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,827 |
1,397 |
$3K |
| 83690 |
|
701 |
558 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,367 |
3,154 |
$3K |
| 83540 |
|
478 |
447 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
242 |
165 |
$3K |
| 81001 |
|
1,656 |
1,354 |
$3K |
| 80061 |
Lipid panel |
1,165 |
1,128 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,401 |
1,168 |
$2K |
| 82150 |
|
246 |
197 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
1,228 |
739 |
$2K |
| 83735 |
|
974 |
785 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
173 |
117 |
$2K |
| 83605 |
|
1,091 |
822 |
$2K |
| 81003 |
|
2,225 |
1,813 |
$2K |
| 85651 |
|
272 |
238 |
$1K |
| 86140 |
|
261 |
227 |
$1K |
| 85027 |
|
1,960 |
1,769 |
$1K |
| 85610 |
|
1,077 |
753 |
$1K |
| 97161 |
|
148 |
127 |
$1K |
| 82728 |
|
185 |
159 |
$1K |
| 87186 |
|
432 |
380 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,707 |
1,264 |
$974.94 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
311 |
132 |
$907.70 |
| 87077 |
|
495 |
434 |
$843.36 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
193 |
167 |
$837.00 |
| 84703 |
|
195 |
159 |
$823.45 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
699 |
491 |
$679.13 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,413 |
1,107 |
$633.92 |
| 80306 |
|
253 |
216 |
$627.66 |
| 81025 |
|
248 |
187 |
$610.20 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
179 |
148 |
$527.33 |
| 83550 |
|
95 |
88 |
$513.90 |
| 84439 |
|
30 |
25 |
$511.20 |
| 82607 |
|
168 |
154 |
$494.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
754 |
600 |
$437.43 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
163 |
108 |
$349.48 |
| 84484 |
|
869 |
648 |
$343.93 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
369 |
340 |
$310.23 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
370 |
340 |
$306.13 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
13 |
$270.90 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
36 |
29 |
$270.00 |
| 82077 |
|
126 |
111 |
$265.50 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
307 |
235 |
$243.72 |
| 73610 |
|
46 |
36 |
$226.80 |
| J2704 |
Injection, propofol, 10 mg |
143 |
110 |
$187.65 |
| 85730 |
|
59 |
51 |
$184.19 |
| 82746 |
|
73 |
66 |
$172.80 |
| 99000 |
|
705 |
568 |
$171.90 |
| 85379 |
|
190 |
136 |
$171.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
140 |
104 |
$103.50 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
47 |
27 |
$44.40 |
| 82962 |
|
18 |
13 |
$37.80 |
| 85652 |
|
18 |
16 |
$27.90 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
526 |
451 |
$21.49 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
123 |
89 |
$17.08 |
| G0378 |
Hospital observation service, per hour |
17 |
12 |
$0.00 |
| 82550 |
|
34 |
31 |
$0.00 |
| 96376 |
|
14 |
12 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
143 |
51 |
$0.00 |
| 86850 |
|
30 |
26 |
$0.00 |
| 82553 |
|
30 |
27 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
69 |
49 |
$0.00 |
| 83874 |
|
30 |
27 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
13 |
12 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
56 |
38 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
13 |
13 |
$0.00 |
| 76377 |
|
19 |
13 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
19 |
12 |
$0.00 |
| 86900 |
|
46 |
39 |
$0.00 |
| 82570 |
|
13 |
12 |
$0.00 |
| 73562 |
|
80 |
62 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
41 |
13 |
$0.00 |